Close Menu
New York Examiner News

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    Kaitlyn Aurelia Smith Launches Label With New Album Ruin: It’s Not Just Music

    May 24, 2026

    Law enforcement authorities respond to reports of shots fired near White House as Trump was inside

    May 24, 2026

    Half Of GOP Senators Were Ready To Vote With Democrats To Kill Trump’s Slush Fund

    May 24, 2026
    Facebook X (Twitter) Instagram
    New York Examiner News
    • Home
    • US News
    • Politics
    • Business
    • Science
    • Technology
    • Lifestyle
    • Music
    • Television
    • Film
    • Books
    • Contact
      • About
      • Amazon Disclaimer
      • DMCA / Copyrights Disclaimer
      • Terms and Conditions
      • Privacy Policy
    New York Examiner News
    Home»Science»AI Digital Twins Are Helping People Manage Diabetes and Obesity
    Science

    AI Digital Twins Are Helping People Manage Diabetes and Obesity

    By AdminFebruary 18, 2026
    Facebook Twitter Pinterest LinkedIn WhatsApp Email Reddit Telegram
    AI Digital Twins Are Helping People Manage Diabetes and Obesity


    Based on logged meals, the app predicts a person’s blood sugar response to those foods. It also makes personalized recommendations throughout the day, such as adjusting portion size, choosing a different food combination, or taking a walk after eating. Users can accept or ignore these suggestions—maybe broccoli isn’t their favorite food, or they prefer to exercise during a particular time of the day. The app uses AI to adapt to their preferences over time. Users can also chat with human coaches if they have specific health questions.

    For Buckley, Twin Health has helped him make healthier choices, such as swapping out frozen, prepackaged breakfast sandwiches for homemade breakfast burritos with low-carb, high-fiber wraps. He no longer drinks soda, and he walks several miles a day.

    “When I first started the program, I could barely make it a mile before my back was hurting, my knee was hurting. Now I’m doing six and a half miles every morning,” he says.

    He likes getting instant feedback from the app and also tracking his biometrics over time. He can see that his body fat percentage and blood pressure have been trending downward.

    “That’s where I get my motivation to keep walking and keep doing the work,” he says.

    Buckley reached his initial weight goal of 300 pounds and is now around 275. After being on blood pressure medication for decades, his doctor recently suggested a lower dose.

    When Twin Health approached the Cleveland Clinic’s health plan about using its program, staff endocrinologist Kevin Pantalone was initially skeptical. He decided to conduct a study himself.

    “We have really struggled to implement lifestyle modification in a very effective manner. Patients often require numerous therapies to control their diabetes,” he said. “So I was certainly very interested.” Despite the age-old advice of simply exercising more and eating healthy, most Americans struggle to get the recommended amount of weekly physical activity and have difficulty sticking to a healthy diet.

    Pantalone and his colleagues recruited 150 participants with type 2 diabetes, randomly assigning 100 people to the Twin program and the rest to a control group. On average, participants were 58 years old with obesity and had a blood glucose level, or A1C, of 7.2 percent. A level of 6.5 percent or higher indicates diabetes. The goal of the trial was to see if participants could reach an A1C of less than 6.5 percent with fewer medications.

    After 12 months, 71 percent of the study participants using the Twin app achieved that blood sugar level with fewer medications, whereas only 2 percent of people in the control group did. The people using Twin also lost more weight—8.6 percent of their body weight versus 4.6 percent in the control group.

    At the beginning of the study, 41 percent of those using Twin were on a GLP-1 medication, but by the end of the study, only 6 percent still were. In the control group, 52 percent of participants started off on a GLP-1, and at the end of the study that increased to 63 percent. The results were published in the New England Journal of Medicine Catalyst last year.



    Original Source Link

    Share. Facebook Twitter Pinterest LinkedIn WhatsApp Email Reddit Telegram
    Previous Article‘Who Framed Roger Rabbit’ Animator Was 91
    Next Article U.S. court bars OpenAI from using ‘Cameo’

    RELATED POSTS

    Quantum ‘Jamming’ Could Help Unlock the Mysteries of Causality

    May 23, 2026

    SpaceX launches Starship V3—the world’s most powerful and tallest rocket ever

    May 23, 2026

    Mercury may have gained all of its unexpected water in a single day

    May 22, 2026

    All the Fancy Measuring Devices Used in Science Rely on Two Stone-Age Techniques

    May 22, 2026

    Hidden structural features inside Egypt’s Great Pyramid may have helped it withstand earthquakes, new study finds

    May 21, 2026

    Women’s body temperature rises from age 18 to 42 but we don’t know why

    May 21, 2026
    latest posts

    Kaitlyn Aurelia Smith Launches Label With New Album Ruin: It’s Not Just Music

    Kaitlyn Aurelia Smith is readying a new album. The composer and synthesist will release Ruin:…

    Law enforcement authorities respond to reports of shots fired near White House as Trump was inside

    May 24, 2026

    Half Of GOP Senators Were Ready To Vote With Democrats To Kill Trump’s Slush Fund

    May 24, 2026

    Giants’ Abdul Carter and Jaxson Dart squash potential locker room rift over Trump event appearance

    May 24, 2026

    Memorial Day Dyson Vacuum Deals: V15 Detect, Gen5Detect, PencilVac On Sale

    May 24, 2026

    Quantum ‘Jamming’ Could Help Unlock the Mysteries of Causality

    May 23, 2026

    2026 Cannes Film Festival 5 Takeaways: AI, Queer Cinema

    May 23, 2026
    Categories
    • Books (1,261)
    • Business (6,165)
    • Events (54)
    • Film (6,102)
    • Lifestyle (4,199)
    • Music (6,219)
    • Politics (6,164)
    • Science (5,519)
    • Technology (6,097)
    • Television (5,784)
    • Uncategorized (7)
    • US News (6,153)
    popular posts

    Roc Nation’s co-presidents are building a new era of music icons for Jay-Z’s empire

    Sitting at the heart of Roc Nation’s music empire are two executives masterfully orchestrating a…

    U.S. Trade Deficit Shrank in July

    September 7, 2022

    The Most Common Questions About The Novavax COVID Vaccine, Answered

    June 10, 2022

    5 Fall Boots Worthy of Your Collection (and How to Style Them)

    October 6, 2022
    Archives
    Browse By Category
    • Books (1,261)
    • Business (6,165)
    • Events (54)
    • Film (6,102)
    • Lifestyle (4,199)
    • Music (6,219)
    • Politics (6,164)
    • Science (5,519)
    • Technology (6,097)
    • Television (5,784)
    • Uncategorized (7)
    • US News (6,153)
    About Us

    We are a creativity led international team with a digital soul. Our work is a custom built by the storytellers and strategists with a flair for exploiting the latest advancements in media and technology.

    Most of all, we stand behind our ideas and believe in creativity as the most powerful force in business.

    What makes us Different

    We care. We collaborate. We do great work. And we do it with a smile, because we’re pretty damn excited to do what we do. If you would like details on what else we can do visit out Contact page.

    Our Picks

    Quantum ‘Jamming’ Could Help Unlock the Mysteries of Causality

    May 23, 2026

    2026 Cannes Film Festival 5 Takeaways: AI, Queer Cinema

    May 23, 2026

    Khloe Kardashian In New Romance With Oscar-Winning Actor?

    May 23, 2026
    © 2026 New York Examiner News. All rights reserved. All articles, images, product names, logos, and brands are property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Terms & Conditions and Privacy Policy.

    Type above and press Enter to search. Press Esc to cancel.

    We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
    Cookie SettingsAccept All
    Manage consent

    Privacy Overview

    This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
    Necessary
    Always Enabled
    Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
    CookieDurationDescription
    cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
    cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
    cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
    cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
    cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
    viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
    Functional
    Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
    Performance
    Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
    Analytics
    Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
    Advertisement
    Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
    Others
    Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
    SAVE & ACCEPT